HPV-RELATED CARCINOMA
Clinical trials for HPV-RELATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Family members vaccinated to fight Relative's HPV cancer
Disease control ENROLLING_BY_INVITATIONThis study is testing a special vaccine for healthy relatives of patients with advanced HPV-linked cancer. The goal is to see if the vaccine safely boosts the donor's immune cells against HPV. Those immune cells are then collected and given to the sick family member in a separate…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New Two-Pronged attack tested for tough HPV cancers
Disease control OngoingThis study is testing a new combination of two drugs, TG4001 and avelumab, for people with advanced HPV-16 positive cancers that have returned or spread. The goal is to see if using these drugs together is safe and more effective at controlling the cancer than using avelumab alon…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
First human test of new drug for HPV cancers begins
Disease control OngoingThis is an early safety study to find the highest safe dose and identify side effects of an experimental drug called IBRX-042 for people with HPV-related cancers that have returned or progressed. It will involve about 12 participants who have already tried standard treatments. Th…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Custom immune cells unleashed against multiple cancers in pioneering trial
Disease control OngoingThis early-stage study is testing the safety of a new, personalized cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them to better recognize and attack their s…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Could a simple blood test spot throat cancer early?
Diagnosis OngoingThis study is testing whether a blood test can help find HPV-related throat cancer early. Researchers are enrolling adults aged 45+ with certain sexual histories who have not had this cancer before. The goal is to see if looking for traces of HPV in the blood is a practical way t…
Matched conditions: HPV-RELATED CARCINOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Diagnosis
Last updated Mar 27, 2026 12:37 UTC